Growth of cardiac myocytes is traditionally divided into two categories; namely the increase in cell numbers which is observed during embryonic development (hyperplastic growth), and the increase in cell mass which is observed during neonatal life (hypertrophic growth). The gene products which regulate these different types of myocardiocyte growth remain largely uncharacterized. The experiments in this proposal are designed to identify and clone gene which regulate proliferation in myocardiocytes. the experiments are based on a transgenic model system in which expression of the SV40 large T antigen oncogene was targeted to the cardiac atria with the Atrial Natriuretic Factor promoter. The transgenic mice develop unilateral right atrial hyperplasia; the hyperplastic atria are comprised of differentiated, dividing myocytes. This model demonstrates that adult myocardiocytes can re-enter the cell cycle in response to viral oncogene expression. Further analysis of the transgenic mice has revealed several properties which provide experimental inroads to identify and clone other genes which control observations. Specifically, we will: 1) Identify and clone the gene which promotes constitutive myocardiocyte hyperplasia in the transgenic model. A genetic variant has been identified which is able to complement T antigen and induce constitutive hyperplasia in atrial myocytes. A combination of genetic and molecular approaches is proposed to identify and clone this gene. 2) characterize the growth requirements of myocardiocytes in culture. We have generated a putative cardiac cell line derived from the transgenic tissue. These myocardiocytes divide rapidly in culture, retain a highly differentiated cardiocyte phenotype, can be repeatedly passaged, and exhibit spontaneous electrical and contractile activities. Clone genes which, when altered, produce a hyperplastic response in transgenic myocardiocytes. Atrial hyperplasia in the transgenic model can follow a pattern which is dependent upon stocastic genetic alterations (mutations). We propose to use a variation of standard oncogene transfection studies to clone the genes which facilitate a hyperplastic response. 4) Identify the array of genes which are expressed specifically in proliferating myocardiocytes. We will perform comprehensive screens to identify gene products who's expression is specifically induced (or repressed) during myocardiocyte proliferation. 5) Further develop second transgenic model system in which T antigen is targeted to cardiac myocytes with the alpha-Myosin Heavy Chain promoter. Initial experiments indicated that ventricular myocytes can also exhibit a hyperplastic response to T antigen. We will characterize ventricular hyperplasia in this new model, and further we will apply the approaches described above to this new system. These experiments will help resolve a fundamental question in cardiology; namely what genes regulate myocardiocyte growth. Once these genes are identified, studies aimed at assessing stimuli (hormonal or chemical) which mediate their expression may ultimately provide a therapeutic basis for myocardiocyte regeneration in vivo.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045453-05
Application #
3364436
Study Section
Special Emphasis Panel (SRC (DW))
Project Start
1990-07-01
Project End
1995-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Pajak, L; Jin, F; Xiao, G H et al. (1997) Sustained cardiomyocyte DNA synthesis in whole embryo cultures lacking the TSC2 gene product. Am J Physiol 273:H1619-27
Soonpaa, M H; Field, L J (1997) Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 272:H220-6
Kim, K K; Daud, A I; Wong, S C et al. (1996) Mouse RAD50 has limited epitopic homology to p53 and is expressed in the adult myocardium. J Biol Chem 271:29255-64
Soonpaa, M H; Kim, K K; Pajak, L et al. (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271:H2183-9
Klug, M G; Soonpaa, M H; Field, L J (1995) DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol 269:H1913-21
Soonpaa, M H; Daud, A I; Koh, G Y et al. (1995) Potential approaches for myocardial regeneration. Ann N Y Acad Sci 752:446-54
Kim, K K; Soonpaa, M H; Wang, H et al. (1995) Developmental expression of p107 mRNA and evidence for alternative splicing of the p107 (RBL1) gene product. Genomics 28:520-9
Hassankhani, A; Steinhelper, M E; Soonpaa, M H et al. (1995) Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol 169:309-21
Cook, J L; Bhandaru, S; Giardina, J F et al. (1995) Identification and antisense inhibition of a renin-angiotensin system in transgenic cardiomyocytes. Am J Physiol 268:H1471-82
Borisov, A B; Claycomb, W C (1995) Proliferative potential and differentiated characteristics of cultured cardiac muscle cells expressing the SV40 T oncogene. Ann N Y Acad Sci 752:80-91

Showing the most recent 10 out of 23 publications